|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/705 | |
| C07K 16/18 | |||
| A61K 38/16 | |||
| A61K 38/17 | |||
| A61K 38/45 | |||
| A61K 39/395 |
| (11) | Patento numeris | 3233902 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15871120.0 |
| Europos patento paraiškos padavimo data | 2015-12-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-09-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/066498 |
| Data | 2015-12-17 |
| (87) | Numeris | WO 2016/100738 |
| Data | 2016-06-23 |
| (30) | Numeris | Data | Šalis |
| 201462093937 P | 2014-12-18 | US |
| (72) |
MIAO, Yu Rebecca, US
TABIBIAZAR, Raymond, US
GIACCIA, Amato J., US
KARIOLIS, Mihalis, US
|
| (73) |
Aravive Biologics, Inc.,
LyondellBasell Tower 1221 McKinney, Suite 3200, Houston, TX 77010,
US
The Board of Trustees of the Leland Stanford Junior University, Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US |
| (54) | ANTIFIBROTIC ACTIVITY OF GAS6 INHIBITOR |
| ANTIFIBROTIC ACTIVITY OF GAS6 INHIBITOR |